Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. - Wikidata - thesis-toulmin - TriplyDB

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

http://www.wikidata.org/entity/Q30452636

about

Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians Management of borderline resectable pancreatic cancer Pancreatic cancer surgery: past, present, and future Management of borderline and locally advanced pancreatic cancer: where do we stand?New challenges in perioperative management of pancreatic cancer Advances in chemotherapy for pancreatic cancer Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.Neoadjuvant therapy in pancreatic cancer: an emerging strategy Borderline resectable pancreatic cancer: definitions and management.Improving outcomes in pancreatic cancer: key points in perioperative management Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future.Neoadjuvant therapy of pancreatic cancer: the emerging paradigm?The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery.Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques.Improving Survival of Pancreatic Cancer. What Have We Learnt?Preoperative Biliary Drainage in Cases of Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy and Surgery.Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer.Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.Minimally invasive radical pancreatectomy for left-sided pancreatic cancer: current status and future perspectives.Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.Role of radiation therapy in the management of pancreatic cancer.Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter?Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.Stereotactic body radiation therapy in pancreatic cancer: the new frontier.Pancreatic cancer: current management and treatment strategies.The role of neoadjuvant therapy in pancreatic cancer: a review.Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy.

P2860

Q26767041-145521BA-B064-4896-B56D-2ECCA9D937D8 Q26781445-4A883A53-C888-4601-BBAA-C8D136EC8BFA Q26781555-DCF51283-727A-4AF0-8702-7F077DD3C120 Q26825414-CD529BAA-BF32-4CA8-8C6F-0E2ECF427588 Q28082422-29FEC35E-21FD-4B9C-8614-D02B3CA88D2B Q28085711-BA5371DC-ED8C-4F6C-836B-5C228A26D937 Q30414737-01508D2D-BBDE-4900-B8B6-6984E6BCC501 Q30423279-97BB39AB-7A13-464F-A7A7-0B18814CF3B5 Q33408075-A56E29A4-040C-40B6-8792-4A746DC70724 Q33914671-04EF85F7-204A-4C90-A496-600C717873F3 Q34067852-F9397F91-B929-4CFD-AD67-21EB1A00EEE6 Q34366880-6541E5AF-15BD-4F23-BB7E-5685A98A2139 Q35155573-F6F79BB5-B3D2-44F2-B1F4-B55D0DA53489 Q35604577-162BAA1F-EECE-4D94-9441-4B58EBD9F769 Q35776229-067CB6B4-94E2-4B90-B2C0-4B61BC2651EF Q35830135-A9C614BE-D9E3-41EF-AC8D-284436C6614D Q36023889-26A57D8D-988F-4905-ABC5-B1FD88A89CBE Q36159880-CBA29CBD-345C-4EDE-AC48-11EAC46CA8A7 Q36262787-C45FB029-4209-444B-9682-CF9CF4670473 Q36400047-FF8EF1E4-D4C3-4F98-A511-090407A8807C Q36531542-967EE660-AC20-439A-B6E8-FDB3D96CE2B1 Q36558415-FE459357-022E-4BA5-9585-3ACFCC686E19 Q36668274-AF86D93F-6981-4B24-B593-5E08F33FA223 Q36746016-CFAD725B-5FE7-4CA7-ADBE-6B0566C3A36D Q36764997-A325F2EB-E0F9-45D8-BF04-185CA89385E5 Q36773130-8A9CA2F8-A8B6-435F-BA23-736FA56847E8 Q37033444-00E06FE0-43E7-4263-A74C-7351A8C36232 Q37131693-AD372AAE-CEFB-4229-82FD-9154A3E2964B Q37525315-6D292CBA-92B6-45CA-909D-66EE477FBA29 Q37617974-CE4D958D-F279-4D3F-A0E9-F6ABDCE5CF86 Q37945640-0C1A077C-ED03-42FB-9966-FB6139BC3ED5 Q38005349-8D476C87-82B7-4B9B-B7DB-CADB956D3BAE Q38084124-806DE480-7A34-49BB-8DD1-61838196CC3F Q38180310-1B27DF2A-B474-4426-A225-9EABE7FC37C9 Q38212152-CE1AB16C-87A2-428E-ACE9-6E65BA87B0B8 Q38245676-4B9762B9-C1BF-4C00-9BA2-0A40F237924D Q38561099-54B01302-4143-4CD4-AAA7-08431EBCB146 Q38734981-83A69F81-5242-4CEA-B28F-F63BA2516894 Q38838295-A137AEF8-A4DB-4940-99F0-7F74A5EEB242 Q38954668-6756EFB0-DF64-4428-874A-56605AA1652B

P2860

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

http://www.wikidata.org/entity/Q30452636

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Preoperative capecitabine and ...... resectable pancreatic cancer.

@ast

Preoperative capecitabine and ...... resectable pancreatic cancer.

@en

type

label

Preoperative capecitabine and ...... resectable pancreatic cancer.

@ast

Preoperative capecitabine and ...... resectable pancreatic cancer.

@en

prefLabel

Preoperative capecitabine and ...... resectable pancreatic cancer.

@ast

Preoperative capecitabine and ...... resectable pancreatic cancer.

@en

P1433

Q30452636-7D1F4662-E79D-41F6-AAA8-3ADFD5460E9F

P1476

Q30452636-83BF8463-5E42-4735-9F77-CC4E8859B72F

P2093

Q30452636-1ACF27B2-AD38-4E94-9A93-731DE3290DB7

Q30452636-4D180B38-DD60-4143-81B5-006C52BBC575

Q30452636-5D374AEE-0D82-4782-89F4-3B0178ED715F

Q30452636-9C96A6B1-8E61-4885-AB48-5B2502221365

Q30452636-A2863182-61B0-46B8-AF35-418C5A0D970B

Q30452636-B58BBD95-76B5-47C6-A32C-48F817833BF5

Q30452636-CF60D57A-1E2B-4687-8B6A-BCB5056E6CA0

Q30452636-F34BDE0B-CCF6-4771-B676-08C3B827947F

P2860

Q30452636-16BB678B-95D5-485B-A47B-B332E1023419

Q30452636-16E9D5E7-A0D1-467C-92E5-990D9FEFCB72

Q30452636-1B2127DB-3795-4B81-BE3F-3DA4C52832C5

Q30452636-1F06AA83-CDD6-4E16-AB16-39879749D6ED

Q30452636-26AF91CE-83CE-4270-AB5A-1472C8C0399B

Q30452636-36F473FF-855D-4DF2-A8C1-152E644C47B8

Q30452636-384D89CC-27B9-4C41-909A-ECD0C088879B

Q30452636-3F335026-5C45-4807-B524-06ACBAA41076

Q30452636-43A09600-FB6E-409B-AEC6-484172058A4D

Q30452636-5FDC188B-D032-4A89-8513-4894138E5E4D

P2888

Q30452636-ADE1F09F-958D-47B0-8E89-F81681D754D9

P304

Q30452636-9DAF387A-93CC-405B-8983-815FE8CA36BB

P31

Q30452636-F5E765A5-608F-4014-96BA-6C89D1BB82ED

P356

Q30452636-37E6F415-2C8D-4007-94C8-C2EFC2910AD0

P433

Q30452636-B78D4441-50B6-43C9-94E3-3A05CDCCCB55

P478

Q30452636-8F54E883-86B7-4138-910B-59EE5C786D31

P50

Q30452636-4B525B5B-4E79-46A9-8827-243EBAA9A0AC

P577

Q30452636-C8A107BA-BAB9-424D-B785-C3C83F329B95

P5875

Q30452636-617BEF80-767C-4837-B60B-32F6FE00B8C5

P6179

Q30452636-CB9700FF-79F6-4F39-8493-13DC2F8E51E3

P698

Q30452636-66E7BE53-31C8-4CBA-98CA-F02035FDC215

P356

S10434-010-1456-7

P1433

Annals of Surgical Oncology

P1476

Preoperative capecitabine and ...... resectable pancreatic cancer.

@en

P2093

Dustin M Walters

http://www.w3.org/2001/XMLSchema#string

Edward B Stelow

http://www.w3.org/2001/XMLSchema#string

Geoffrey R Weiss

http://www.w3.org/2001/XMLSchema#string

Jayme B Stokes

http://www.w3.org/2001/XMLSchema#string

Norris J Nolan

http://www.w3.org/2001/XMLSchema#string

Reid B Adams

http://www.w3.org/2001/XMLSchema#string

Todd W Bauer

http://www.w3.org/2001/XMLSchema#string

Tyvin A Rich

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.

Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.

A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.

P2888

s10434-010-1456-7

P304

619-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-010-1456-7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Eduard E de Lange

P577

2011-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49735316

http://www.w3.org/2001/XMLSchema#string

P6179

1004479121

http://www.w3.org/2001/XMLSchema#string

P698

21213060

http://www.w3.org/2001/XMLSchema#string